Brian Hasslinger, MD
Otolaryngic Allergy · Cumberland, MDNPI 1457380602
Payments from drug & device makers
Across 11 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$47
- Stryker$33
- Alk-abello, Inc$22
- ARS Pharmaceuticals Operations, Inc.$19
- Acelrx Pharmaceuticals, Inc.$16
- Acclarent, Inc$16
- plus $42 from 3 others
What the payments were for
- Food & beverage$196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 3 | $47 |
| Stryker | 1 | $33 |
| Alk-abello, Inc | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Acelrx Pharmaceuticals, Inc. | 1 | $16 |
| Acclarent, Inc | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Sanofi | 1 | $13 |
How this compares
Too few otolaryngic allergy providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 269 | $11,196 |
| Azelastine Hcl | 71 | $2,492 |
| Montelukast Sodium | 150 | $2,440 |
| Ofloxacin | 57 | $2,305 |
| Nystatin | 52 | $1,579 |
| Fluticasone Propionate | 78 | $1,518 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $1,400 |
| Fluocinolone Acetonide Oil | 41 | $1,264 |
| Clotrimazole | 33 | $1,020 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 13 | $670 |
| CefuroximeCefuroxime Axetil | 34 | $576 |
| Gentamicin Sulfate | 11 | $472 |
| Acetic Acid | 16 | $300 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $279 |
| Prednisone | 59 | $271 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.